Photobiomodulation and Skin Cancer: Summary of Current Evidence
INTRODUCTION- The Integrative Health Research Center/IHRC in NYC conducted a 2-year performance study in the use of various LED-based near-infrared light health devices. The test was aptly named "Scan & Treat" whereby each model was tested on consenting subjects (as directed by its accompanying instructions and training programs). Brands ranged in frequency and design supporting various health claims. All devices under review presented documentation and instructions based on each manufacturer's standard testing policies as approved by regulatory agencies for public market.
Additional concern is PBMT's effects on cancers, especially skin cancers and melanoma where direct exposure of this 'light therapy' on an infected area may awaken or aggravate the cancer's malignancy. Where PBMT is identified on the market (and with the brand's marketing claims) to reduce inflammation, an adverse concern is for the potential unknowns of a tumor's aggressiveness to be provoked by the device's exposure.
The following are statements and findings from a 2nd and 3rd level academic data search. All references and expanded details are accessible by the links enclosed.
SAFETY INQUIRY/REVIEW (10-19-2024)
An academic research/report by:
Dr. Roberta Kline - editor, HealthTech Reporter / Women's Health Digest
LED (Light Emitting Diode) is often included in PBMT and
while around since the late 1920’s it is only since the late 1960’s that it has
been used therapeutically. Its use is increasing in therapeutic applications as
it is less expensive than laser. [De Pauli Paglioni,
et al]
They both operate within defined spectrums of light, with visible red being 600-700 nm and near-infrared (NIR) being 700-1400nm. These wavelengths correspond to the maximal absorption of skin without creating heat. [Torres, Angeli E et al.]
While there are differences between LLLT and LED, they have been found to be equally effective in many use cases, including wound healing, inflammation, and pain relief. [Torres, Angeli E et al.]
Table 1 source: Torres,
Angeli E et al.
PBMT works via absorption by mitochondrial chromophores
including Cytochrome c oxidase and flavoenzymes, which facilitate electron
transport and ATP synthesis. It also is involved in release of nitric oxide
(NO) which is involved in mitochondrial antioxidant defense and would account
for clinical and research observations that PBMT helps to mitigate oxidative
damage from radiation or chemotherapy. Gene expression influenced to enhance
regeneration and repair, including cell proliferation & migration, immune
and angiogenesis. [Glass GE.]
Cells with higher concentrations of mitochondria appear to require lower doses for therapeutic effects, whereas cells such as fibroblasts and keratinocytes require more due to lower mitochondrial density. [Glass GE]
Multiple cell culture and animal studies have shown that PBMT has little or no effect on cancer cell viability, nor does it induce neoplastic changes in normal cells. The rare studies that showed a possible effect were in animals with compromised immune systems. [Glass GE]
A large review published by Bensadoun RJ et al in 2020 showed that animal studies and clinical trials support the safety of PBMT related to tumor growth, and may even be beneficial for overall survival in patients with cancer. The conflicting results from a few in vitro cell culture studies were felt to be related to doses outside of normal clinical use, and thus not relevant to safety in humans.
In 2022, a position paper from the WALT Congress [Robijns J et al.] stated that PBMT has been shown to have a biphasic dose-response, with lower doses having potentially less effect and higher doses having potentially no beneficial or even adverse effects, that warrants further clinical research to clarity optimal dosage.
They also stated that the genetic variability of individual tumors, as revealed by the technology of precision oncology, may contribute to variable response to PBMT. Indeed, some tumors have genetic variations in genes that are targeted by PBMT, such as PI3K. One example is squamous cell cancers of the mouth, where up to 35% of tumors have alterations in the PI3K pathway. Thus, further research with this more individualized approach is needed and should replace one-size-fits-all approaches.
Their conclusion was that, although PBMT is generally safe for patients with cancer, there is a lack of definitive evidence regarding potential enhancement of tumor growth and long-term survival, thus more clinical trials and robust data regarding use with cancer are needed. They also specifically did not recommend direct treatments to the tumor, and advised that all patients should be fully informed of the potential benefits and risks.
References:
1) Glass GE. Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation. Aesthet Surg J. 2023 Apr 10;43(5):NP357-NP371. doi: 10.1093/asj/sjad018.
2) De Pauli Paglioni, Mariana, et al. "Tumor Safety and Side Effects of Photobiomodulation Therapy Used for Prevention and Management of Cancer Treatment Toxicities. A Systematic Review." Oral Oncology, vol. 93, 2019, pp. 21-28, https://doi.org/10.1016/j.oraloncology.2019.04.004.
3) Torres, Angeli E., and Henry W. Lim. "Photobiomodulation for the Management of Hair Loss." Photodermatology, Photoimmunology & Photomedicine, vol. 37, no. 2, 2021, pp. 91-98, https://doi.org/10.1111/phpp.12649.
4) Bensadoun RJ, Epstein JB, Nair RG, et al. World Association for Laser Therapy (WALT). Safety and efficacy of photobiomodulation therapy in oncology: A systematic review. Cancer Med. 2020 Nov;9(22):8279-8300. doi: 10.1002/cam4.3582.
5) Robijns, Jolien, et al. "Photobiomodulation Therapy in Management of Cancer Therapy-induced Side Effects: WALT Position Paper 2022." Frontiers in Oncology, vol. 12, 2022, p. 927685, https://doi.org/10.3389/fonc.2022.927685
PART 2: HEALTH VISIONARY SPOTLIGHT
Transcript from the interview with Dr. Scott Schaffer (4/19/2023)
The Theralight 360 is one of the few full-body red light therapy units on the market. Other common terms for red light therapy are photobiomodulation (PBM), low level laser therapy, cold laser therapy or near infrared red therapy (NIR). In a nutshell, red light therapy is scientifically supported to benefit and treat conditions caused by the pervasive suffix “itis”, more commonly known as INFLAMMATION. I purchased the Theralight 360 approximately 3+ years ago in search of more for my patients. I do a lot of good with conventional chiropractic work, but there's always evolving treatment options out there in the therapeutic and clinical world. You just have to do a little digging and climbing to find it. I first learned about the growing use of red light therapy (light-emitting diodes and laser diodes) from an oral surgeon who used this technology to help expedite healing in post-surgical patients. He seemed to have great success with it, so I went on a red light therapy journey.  |
| Source: theralight.com |
Comparatively the Theralight 360 is not an expensive treatment but it's not always easy to get people to try it since this treatment must be paid for "out of pocket". So, in an effort to give a patient the experience of red light therapy I will offer them a "trial" so they can at least feel the positive effects of the healing light before making financial decision. First and foremost, even if you don't see immediate results, it feels fantastic being in Theralight 360 (laugh). The 15-20 minute session is extremely comforting – what I would imagine being in the womb may feel like or a cocoon of warm light. Typically, the first thing people report is a “tingling” feeling during the session, this is because the body releases a substance called nitric oxide during the treatment causing your arteries to dilate thus improving circulation. Another common bonus of being exposed to the red light is that clients will typically experience a very sound sleep that evening (yes, we treat people with difficulty sleeping also).
 |
| Source: Westchester Total Health |
# # #
RELATED ARTICLES
 |
| Check out our sponsor |
FROM THE BRAIN HEALTH COLLABORATIVE
11/18/2022- RED LIGHT THERAPY FOR TBI (By: Jennifer Stagg, ND) Within the past decade, ads for Red Light Therapy (RLT) devices have exponentially appeared in the health, wellness and commercial markets- drawing significant attention to their claims and challenging their efficacy. As with all technologies, many variables are to be considered as far as concluding on their proposed health benefits. Published reports from clinical (valid) studies detailing the utility of RLT in human health. Encouraging reviews indicate that there is a growing body of evidence for the use of RLT in traumatic brain injury (TBI) and neurodegenerative processes, including Stroke and Parkinson’s disease.
Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.
.jpg)
